tiprankstipranks
SELLAS Life Sciences Announces Executive Shake-up and Reorganization Strategy
Company Announcements

SELLAS Life Sciences Announces Executive Shake-up and Reorganization Strategy

Don't Miss Our New Year's Offers:

SELLAS Life Sciences Group (SLS) has shared an update.

SELLAS Life Sciences Group, Inc. is undergoing significant executive restructuring, with the termination of Barbara A. Wood, the Executive Vice President, and Robert Francomano, the Senior Vice President, both without cause. The company is arranging separation agreements with the outgoing executives and has announced a strategic reorganization focusing on commercialization partnerships to steer the company towards future growth. Details on the agreements will be shared once finalized.

For a thorough assessment of SLS stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskSELLAS Life Sciences Advances Phase 3 AML Trial
TheFlySellas Life Sciences triggers interim analysis in Phase 3 REGAL trial
TheFlySellas Life Sciences reports OS, ORR data from Phase 2 trial of SLS009
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App